Aerobic exercise improves insulin resistance and decreases body fat and serum levels of leptin in patients with hepatitis C virus

Aim:  Hepatitis C virus infection often complicates glucose intolerance, which can be caused by insulin resistance. Aerobic exercise can improve insulin resistance and decrease body fat in patients with diabetes. The aim of the present study is to clarify whether aerobic exercise improves insulin resistance and decreases body fat in patients with chronic hepatitis C (CH‐C).

[1]  A. Lok,et al.  Reduction of insulin resistance with effective clearance of hepatitis C infection: results from the HALT-C trial. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[2]  Tony Reiman,et al.  Randomized controlled trial of the effects of aerobic exercise on physical functioning and quality of life in lymphoma patients. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  Y. Hiasa,et al.  Diabetes pattern on the 75 g oral glucose tolerance test is a risk factor for hepatocellular carcinoma in patients with hepatitis C virus , 2009, Liver international : official journal of the International Association for the Study of the Liver.

[4]  E. Crivellato,et al.  Leptin–leptin receptor are involved in angiogenesis in human hepatocellular carcinoma , 2008, Peptides.

[5]  M. Manns,et al.  Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus , 2008, Hepatology.

[6]  J. Kirwan,et al.  Exercise and diet enhance fat oxidation and reduce insulin resistance in older obese adults. , 2008, Journal of applied physiology.

[7]  J. Kench,et al.  Insulin resistance and liver injury in hepatitis C is not associated with virus‐specific changes in adipocytokines , 2007, Hepatology.

[8]  M. Amato,et al.  The impact of insulin resistance, serum adipocytokines and visceral obesity on steatosis and fibrosis in patients with chronic hepatitis C , 2007, Alimentary pharmacology & therapeutics.

[9]  W. Hopkins,et al.  Effects of Different Modes of Exercise Training on Glucose Control and Risk Factors for Complications in Type 2 Diabetic Patients: a Meta-Analysis , 2007, Diabetes Care.

[10]  Didier Merlin,et al.  Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells. , 2007, Cancer research.

[11]  Y. Miyazaki,et al.  The Effect of Pioglitazone on the Liver , 2006, Diabetes Care.

[12]  M. Roden,et al.  Hepatic leptin signaling in obesity , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  K. Takehana,et al.  Branched-chain amino acids improve glucose metabolism in rats with liver cirrhosis. , 2005, American journal of physiology. Gastrointestinal and liver physiology.

[14]  R. Andrade,et al.  Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients. , 2005, Gastroenterology.

[15]  K. Koike,et al.  Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance. , 2004, Gastroenterology.

[16]  G. Schuler,et al.  Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure. , 2003, Journal of the American College of Cardiology.

[17]  G. Tomlinson,et al.  High body mass index is an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C , 2003, Hepatology.

[18]  K. Courneya,et al.  Randomized controlled trial of exercise training in postmenopausal breast cancer survivors: cardiopulmonary and quality of life outcomes. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  V. Castellano-Megías,et al.  Serum leptin levels correlate with hepatic steatosis in chronic hepatitis C , 2003, American Journal of Gastroenterology.

[20]  T. Zimmers,et al.  Suppressor of Cytokine Signaling-3 (SOCS-3), a Potential Mediator of Interleukin-6-dependent Insulin Resistance in Hepatocytes* , 2003, The Journal of Biological Chemistry.

[21]  I. Sonaka,et al.  Leucine promotes glucose uptake in skeletal muscles of rats. , 2002, Biochemical and biophysical research communications.

[22]  R. Mooney,et al.  Interleukin-6 induces cellular insulin resistance in hepatocytes. , 2002, Diabetes.

[23]  W. Kraus,et al.  Adiponectin is not altered with exercise training despite enhanced insulin action. , 2002, American journal of physiology. Endocrinology and metabolism.

[24]  Vittorio Cacciatori,et al.  HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study. , 2002, Diabetes care.

[25]  Y. Takei,et al.  Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat. , 2002, Gastroenterology.

[26]  T. Tai,et al.  Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. , 2001, The Journal of clinical endocrinology and metabolism.

[27]  P. Scherer,et al.  The adipocyte-secreted protein Acrp30 enhances hepatic insulin action , 2001, Nature Medicine.

[28]  B. Tom,et al.  Further evidence for an association between non–insulin‐dependent diabetes mellitus and chronic hepatitis C virus infection , 1999, Hepatology.

[29]  N. Turkçapar,et al.  Association of diabetes mellitus and chronic hepatitis C virus infection , 1999, Hepatology.

[30]  E. Kenny‐Walsh.  Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group. , 1999, The New England journal of medicine.

[31]  T Nakamura,et al.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. , 1999, Biochemical and biophysical research communications.

[32]  D. Häussinger,et al.  Prognosis of chronic hepatitis c: Results of a large, prospective cohort study , 1998, Hepatology.

[33]  J. Halaas,et al.  Leptin and the regulation of body weight in mammals , 1998, Nature.

[34]  K. Chayama,et al.  Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients. , 1998, Journal of hepatology.

[35]  L. Tartaglia,et al.  The Leptin Receptor* , 1997, The Journal of Biological Chemistry.

[36]  Patricia R. Johnson,et al.  Relationship of plasma leptin to plasma insulin and adiposity in normal weight and overweight women: effects of dietary fat content and sustained weight loss. , 1996, The Journal of clinical endocrinology and metabolism.

[37]  J. Barberà,et al.  Physical exercise increases portal pressure in patients with cirrhosis and portal hypertension. , 1996, Gastroenterology.

[38]  J. Dufour,et al.  Insulin resistance is associated with liver fibrosis in non-diabetic chronic hepatitis C patients. , 2005, Journal of hepatology.

[39]  P. Bonis.  Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. , 1999, The New England journal of medicine.

[40]  S. Ritland,et al.  Physical activity in liver disease and liver function in sportsmen. , 1982, Scandinavian journal of social medicine. Supplementum.

[41]  J. Garrow.  Weight reduction. , 1975, Proceedings of the Royal Society of Medicine.